Straits Times Index
3,297.55 -26.98 (-0.81%) Nikkei
38,814.56 +94.09 (+0.24%) Hang Seng
17,941.78 -170.85 (-0.94%) FTSE 100
8,146.86 -16.81 (-0.21%) Bitcoin USD
66,232.53 -10.48 (-0.02%) CMC Crypto 200
1,373.99 -43.89 (-3.10%)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ)
| Previous close | 296.16 |
| Open | 304.68 |
| Bid | 295.33 x 0 |
| Ask | 296.32 x 0 |
| Day's range | 288.71 - 297.02 |
| 52-week range | 253.48 - 316.10 |
| Volume | |
| Avg. volume | 3,487,847 |
| Market cap | 362.641B |
| Beta (5Y monthly) | 0.10 |
| PE ratio (TTM) | 29.76 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 10.30 (3.44%) |
| Ex-dividend date | 28 May 2024 |
| 1y target est | N/A |
- PR Newswire
Mindray Expands Its Cardiac Biomarker Portfolio with Cutting-Edge hs-cTnI and NT-proBNP Assays, Empowering Enhanced Cardiovascular Diseases Care
Mindray (SZSE: 300760), a global leader in medical devices and solutions, introduces high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The additions have enhanced Mindray's diverse portfolio of cardiac biomarkers for cardiovascular diseases (CVDs) diagnosis and management.
- CNW Group
Mindray Introduces Innovative Upgrades to A Series Anaesthesia Systems for Enhanced Patient Safety and Efficiency
Mindray (SZSE: 300760), a global leader in providing advanced medical device solutions, has unveiled upgrades to its A7 and A5 anaesthesia systems under the A Series Anaesthesia. These enhancements incorporate innovative technologies that empower anaesthesiologists to deliver precise anaesthesia, leading to greater patient safety and efficiency throughout the perioperative period.
- CNW Group
Mindray and Operation Smile Begin 10-Year Partnership to Improve Healthcare for Vulnerable Communities
Mindray, a leading global provider of medical devices and solutions and Operation Smile, a global nonprofit dedicated to transforming the lives of patients and their communities by increasing access to safe surgery and providing high-quality cleft surgery and comprehensive care, today announced a new 10-year partnership. This solidifies a strategic partnership between the two organizations to collaborate on improving the quality of health care and providing life-changing medical interventions to
